Abstract
Both serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) genes have shown positive associations with obsessive–compulsive disorder (OCD) and some other psychiatric disorders, but these results have not been consistently replicated. To explore the hypothesis that this variability might result from the effects of differing combinations of overlooked variants within SLC6A4 together with small OCD and control sample sizes, we studied three common functional polymorphisms (5-HTTLPR, STin2, and the newly discovered SNP, rs25531) in the largest sample size of OCD patients (N=347) and controls (N=749) ever investigated. During methods development, we found evidence for potential SLC6A4 genotyping problems with earlier methodology, a third possible contributor to variability in earlier studies. A fourth possible explanation might be SLC6A4 × BDNF interactions, which prompted us to investigate combined genotypes of BDNF V66M with the three SLC6A4 loci. Except for a nominal association with rs25531 alone, which did not survive correction for multiple comparisons, we found no evidence for any of these other variants being associated alone or together with OCD, and we therefore also examined clinical OCD subtypes within the sample to evaluate clinical heterogeneity. Subgroups based on the age of OCD onset, gender, familiality, factor analysis-derived symptom dimensions, or comorbidity with other psychiatric disorders failed to identify SLC6A4- or BDNF-associated phenotypes, with one exception of overall number of comorbid anxiety disorders being significantly associated with 5-HTTLPR/rs25531. We conclude that despite their attractiveness as candidate genes in OCD, our data provide no support for association in this large OCD patient sample and point toward the need to examine other genes as candidates for risk determinants in OCD.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Accession codes
References
Angelucci F, Brene S, Mathe AA (2005). BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 10: 345–352.
Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL (2006). Glutamate transporter gene SLC1A1 associated with obsessive–compulsive disorder. Arch Gen Psychiatry 63: 769–776.
Baer L (1994). Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 55 (Suppl): 18–23.
Barrett JC, Fry B, Maller J, Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263–265.
Bengel D, Greenberg BD, Cora-Locatelli G, Altemus M, Heils A, Li Q et al (1999). Association of the serotonin transporter promoter regulatory region polymorphism and obsessive–compulsive disorder. Mol Psychiatry 4: 463–466.
Camarena B, Rinetti G, Cruz C, Hernandez S, de la Fuente JR, Nicolini H (2001). Association study of the serotonin transporter gene polymorphism in obsessive–compulsive disorder. Int J Neuropsychopharmacol 4: 269–272.
Cannings C, Edwards AW (1968). Natural selection and the de Finetti diagram. Ann Hum Genet 31: 421–428.
Cavallini MC, Di Bella D, Siliprandi F, Malchiodi F, Bellodi L (2002). Exploratory factor analysis of obsessive–compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet 114: 347–353.
Chabane N, Millet B, Delorme R, Lichtermann D, Mathieu F, Laplanche JL et al (2004). Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive–compulsive disorder by case control and family association study in humans. Neurosci Lett 363: 154–156.
Cromer KR, Schmidt NB, Murphy DL (in press). An investigation of traumatic life events and obsessive–compulsive disorder. Behav Res Ther [E-pub ahead of print].
Deka R, De Croo S, Yu LM, Ferrell RE (1992). Variable number of tandem repeat (VNTR) polymorphism at locus D17S5 (YNZ22) in four ethnically defined human populations. Hum Genet 90: 86–90.
Delorme R, Betancur C, Wagner M, Krebs MO, Gorwood P, Pearl P et al (2005). Support for the association between the rare functional variant I425V of the serotonin transporter gene and susceptibility to obsessive compulsive disorder. Mol Psychiatry 10: 1059–1061.
Denys D, Van Nieuwerburgh F, Deforce D, Westenberg HG (2006). Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder. J Affect Disord 91: 39–44.
Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M et al (2006). Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive–compulsive disorder. Arch Gen Psychiatry 63: 778–785.
Frisch A, Michaelovsky E, Rockah R, Amir I, Hermesh H, Laor N et al (2000). Association between obsessive–compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur Neuropsychopharmacol 10: 205–209.
Gelernter J, Cubells JF, Kidd JR, Pakstis AJ, Kidd KK (1999). Population studies of polymorphisms of the serotonin transporter protein gene. Am J Med Genet 88: 61–66.
Glatt CE, DeYoung JA, Delgado S, Service SK, Giacomini KM, Edwards RH et al (2001). Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nat Genet 27: 435–438.
Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL et al (1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46: 1006–1011.
Greenberg BD, Li Q, Lucas FR, Hu S, Sirota LA, Benjamin J et al (2000). Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet 96: 202–216.
Greenberg BD, McMahon FJ, Murphy DL (1998). Serotonin transporter candidate gene studies in affective disorders and personality: promises and potential pitfalls. Mol Psychiatry 3: 186–189.
Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M (2003). Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive–compulsive disorder. Am J Hum Genet 73: 370–376.
Hanna GL, Veenstra-VanderWeele J, Cox NJ, Boehnke M, Himle JA, Curtis GC et al (2002). Genome-wide linkage analysis of families with obsessive–compulsive disorder ascertained through pediatric probands. Am J Med Genet 114: 541–552.
Hasler G, Kazuba D, Murphy DL (2006). Factor analysis of obsessive–compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism. Am J Med Genet B Neuropsychiatr Genet 141: 403–408.
Hasler G, LaSalle-Ricci VH, Ronquillo JG, Crawley SA, Cochran LW, Kazuba D et al (2005). Obsessive–compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity. Psychiatry Res 135: 121–132.
Heils A, Teufel A, Petri S, Seemann M, Bengel D, Balling U et al (1995). Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J Neural Transm Gen Sect 102: 247–254.
Hemmings SM, Stein DJ (2006). The current status of association studies in obsessive–compulsive disorder. Psychiatr Clin North Am 29: 411–444.
Hettema JM, Neale MC, Kendler KS (2001). A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158: 1568–1578.
Hranilovic D, Stefulj J, Schwab S, Borrmann-Hassenbach M, Albus M, Jernej B et al (2004). Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol Psychiatry 55: 1090–1094.
Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD et al (2006). Serotonin transporter promoter gain-of-function genotypes are linked to obsessive–compulsive disorder. Am J Hum Genet 78: 815–826.
Kaiser R, Tremblay PB, Roots I, Brockmoller J (2002). Validity of PCR with emphasis on variable number of tandem repeat analysis. Clin Biochem 35: 49–56.
Kaufman J, Yang BZ, Douglas-Palumberi H, Grasso D, Lipschitz D, Houshyar S et al (2006). Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 59: 673–680.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 593–602.
Kilic F, Murphy DL, Rudnick G (2003). A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol 64: 440–446.
Kim SJ, Cox N, Courchesne R, Lord C, Corsello C, Akshoomoff N et al (2002). Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol Psychiatry 7: 278–288.
Kinnear CJ, Niehaus DJ, Moolman-Smook JC, du Toit PL, van Kradenberg J, Weyers JB et al (2000). Obsessive–compulsive disorder and the promoter region polymorphism (5-HTTLPR) in the serotonin transporter gene (SLC6A4): a negative association study in the Afrikaner population. Int J Neuropsychopharmacol 3: 327–331.
Kunugi H, Hattori M, Kato T, Tatsumi M, Sakai T, Sasaki T et al (1997). Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder. Mol Psychiatry 2: 457–462.
LaSalle VH, Cromer KR, Nelson KN, Kazuba D, Justement L, Murphy DL (2004). Diagnostic interview assessed neuropsychiatric disorder comorbidity in 334 individuals with obsessive–compulsive disorder. Depress Anxiety 19: 163–173.
Leal SM (2005). Detection of genotyping errors and pseudo-SNPs via deviations from Hardy–Weinberg equilibrium. Genet Epidemiol 29: 204–214.
Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C et al (1997). Symptoms of obsessive–compulsive disorder. Am J Psychiatry 154: 911–917.
Leckman JF, Pauls DL, Zhang H, Rosario-Campos MC, Katsovich L, Kidd KK et al (2003). Obsessive–compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet 116: 60–68.
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527–1531.
Lesch KP, Gross J, Franzek E, Wolozin BL, Riederer P, Murphy DL (1995). Primary structure of the serotonin transporter in unipolar depression and bipolar disorder. Biol Psychiatry 37: 215–223.
Lovejoy EA, Scott AC, Fiskerstrand CE, Bubb VJ, Quinn JP (2003). The serotonin transporter intronic VNTR enhancer correlated with a predisposition to affective disorders has distinct regulatory elements within the domain based on the primary DNA sequence of the repeat unit. Eur J Neurosci 17: 417–420.
MacKenzie A, Quinn J (1999). A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA 96: 15251–15255.
Mataix-Cols D, Marks IM, Greist JH, Kobak KA, Baer L (2002). Obsessive–compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom 71: 255–262.
McDougle CJ, Epperson CN, Price LH, Gelernter J (1998). Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol Psychiatry 3: 270–273.
Meira-Lima I, Shavitt RG, Miguita K, Ikenaga E, Miguel EC, Vallada H (2004). Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive–compulsive disorder. Genes Brain Behav 3: 75–79.
Miguel EC, Leckman JF, Rauch S, do Rosario-Campos MC, Hounie AG, Mercadante MT et al (2005). Obsessive–compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry 10: 258–275.
Mossner R, Walitza S, Lesch KP, Geller F, Barth N, Remschmidt H et al (2005). Brain-derived neurotrophic factor V66M polymorphism in childhood-onset obsessive–compulsive disorder. Int J Neuropsychopharmacol 8: 133–136.
Munafo MR, Clark T, Flint J (2005). Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta-analysis. Mol Psychiatry 10: 415–419.
Mynett-Johnson L, Kealey C, Claffey E, Curtis D, Bouchier-Hayes L, Powell C et al (2000). Multimarkerhaplotypes within the serotonin transporter gene suggest evidence of an association with bipolar disorder. Am J Med Genet 96: 845–849.
Nakamura M, Ueno S, Sano A, Tanabe H (2000). The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 5: 32–38.
Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P et al (2005). BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 10: 208–212.
Ohara K, Suzuki Y, Ochiai M, Tsukamoto T, Tani K, Ohara K (1999). A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders. Prog Neuropsychopharmacol Biol Psychiatry 23: 55–65.
Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J et al (2003). Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry 8: 933–936.
Pato MT, Pato CN, Pauls DL (2002). Recent findings in the genetics of OCD. J Clin Psychiatry 63 (Suppl 6): 30–33.
Prasad HC, Zhu CB, McCauley JL, Samuvel DJ, Ramamoorthy S, Shelton RC et al (2005). Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc Natl Acad Sci USA 102: 11545–11550.
Purcell S, Cherny SS, Sham PC (2003). Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19: 149–150.
Rasmussen SA, Tsuang MT (1984). The epidemiology of obsessive compulsive disorder. J Clin Psychiatry 45: 450–457.
Ren-Patterson RF, Cochran LW, Holmes A, Lesch KP, Lu B, Murphy DL (2006). Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies. Cell Mol Neurobiol 26: 753–778.
Ren-Patterson RF, Cochran LW, Holmes A, Sherrill S, Huang SJ, Tolliver T et al (2005). Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J Neurosci Res 79: 756–771.
Ribases M, Gratacos M, Fernandez-Aranda F, Bellodi L, Boni C, Anderluh M et al (2004). Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet 13: 1205–1212.
Rosenberg DR, Keshavan MS (1998). A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive–compulsive disorder. Biol Psychiatry 43: 623–640.
Rosenberg PS, Che A, Chen BE (2006). Multiple hypothesis testing strategies for genetic case–control association studies. Stat Med 25: 3134–3149.
Samuels JF, Riddle MA, Greenberg BD, Fyer AJ, McCracken JT, Rauch SL et al (2006). The OCD collaborative genetics study: methods and sample description. Am J Med Genet B Neuropsychiatr Genet 141: 201–207.
Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA et al (2006). Genomewide linkage scan for obsessive–compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 11: 763–770.
Sutcliffe JS, Delahanty RJ, Prasad HC, McCauley JL, Han Q, Jiang L et al (2005). Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet 77: 265–279.
Taylor S (2005). Dimensional and subtyped models of OCD. In: Abramowitz JS, Houts AC (eds). Concepts and Controversies in Obsessive–Compulsive Disorder. Springer: New York. pp 27–42.
Walitza S, Wewetzer C, Gerlach M, Klampfl K, Geller F, Barth N et al (2004). Transmission disequilibrium studies in children and adolescents with obsessive–compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway. J Neural Transm 111: 817–825.
Weissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, Lee CK et al (1994). The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry 55 (Suppl): 5–10.
Wendland JR, DeGuzman TB, McMahon F, Rudnick G, Detera-Wadleigh S, Murphy DL (in press). SERT Ileu425Val in Autism, Asperger Syndrome and obsessive–compulsive disorder. Psychiatr Genet.
Wendland JR, Kruse MR, Murphy DL (2006a). Functional SLITRK1 var321, varCDfs and SLC6A4 G56A variants and susceptibility to obsessive–compulsive disorder. Mol Psychiatry 11: 802–804.
Wendland JR, Martin BJ, Kruse MR, Lesch KP, Murphy DL (2006b). Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry 11: 224–226.
Willour VL, Yao Shugart Y, Samuels J, Grados M, Cullen B, Bienvenu III OJ et al (2004). Replication study supports evidence for linkage to 9p24 in obsessive–compulsive disorder. Am J Hum Genet 75: 508–513.
Yonan AL, Palmer AA, Gilliam TC (2006). Hardy-Weinberg disequilibrium identified genotyping error of the serotonin transporter (SLC6A4) promoter polymorphism. Psychiatr Genet 16: 31–34.
Acknowledgements
We are indebted to Diane Kazuba and Brenda Justement for conducting proband interviews, to Teresa Tolliver and Su-Jan Huang for excellent technical assistance in DNA extraction and general lab maintenance, to Theresa DeGuzman for development of the OCD phenotype database, and to Holly Lasalle and Michael Wheaton for numerous contributions to updating the database. This research was supported by the Intramural Research Program of the NIMH, NIH.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)
Supplementary information
Rights and permissions
About this article
Cite this article
Wendland, J., Kruse, M., Cromer, K. et al. A Large Case–Control Study of Common Functional SLC6A4 and BDNF Variants in Obsessive–Compulsive Disorder. Neuropsychopharmacol 32, 2543–2551 (2007). https://doi.org/10.1038/sj.npp.1301394
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1301394
Keywords
This article is cited by
-
Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway
Molecular Psychiatry (2022)
-
Relevance of polymorphisms in MC4R and BDNF in short normal stature
BMC Pediatrics (2018)
-
Is serotonin transporter polymorphism (5-HTTLPR) allele status a predictor for obsessive-compulsive disorder? A meta-analysis
Archives of Women's Mental Health (2015)
-
A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders
Molecular Autism (2013)
-
Molecular genetics of obsessive–compulsive disorder: a comprehensive meta-analysis of genetic association studies
Molecular Psychiatry (2013)